Delivery Order SPE2DE24D0013-SPE2D625F1PLV
- Not listed
- The U.S. Defense Department's Medical Supply Chain awarded a $2,720 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on August 18, 2025, with an ultimate completion date of August 25, 2025. This delivery order, identified as XPCOV2/FLU/RSV-10, does not utilize a set-aside designation and represents a discrete procurement under one of Cepheid's existing indefinite delivery vehicles with the Department of Veterans...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $2,040 to Cepheid Inc. on August 1, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price delivery order, designated 4568960200 for XPCOV2/FLU/RSV-10, carries no set-aside designation and will be performed at Cepheid's facility in Sunnyvale, California. The delivery order designation suggests this award was issued under a larger indefinite delivery vehicle (IDV) contract, consistent...
- Cepheid Inc., a molecular diagnostic solutions manufacturer based in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $2,040 by the Defense Logistics Agency's Medical Supply Chain division on August 22, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, is scheduled for completion by August 29, 2025, and covers molecular diagnostic testing solutions for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). This award carries no set-aside...
- The U.S. Defense Department's Medical Supply Chain division awarded a $23,475.80 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. The contract, designated XPCOV2/FLU/RSV-10, was awarded on July 29, 2025, with an ultimate completion date of August 12, 2025, and carries no set-aside designation. Work will be performed at Cepheid's Sunnyvale facility. This delivery order represents procurement of diagnostic testing...
- The Defense Department's Medical Supply Chain division awarded a $3,400 firm fixed-price delivery order to Cepheid Inc. on July 30, 2025, for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The contract, designated as delivery order XPCOV2/FLU/RSV-10, is scheduled for completion by August 6, 2025, and will be performed at Cepheid's facility in Sunnyvale, California. This award carries no set-aside designation and represents a...
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a $3,400 firm fixed-price delivery order to Cepheid Inc. on August 1, 2025, with an ultimate completion date of August 8, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic solutions for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). Cepheid, a for-profit molecular diagnostics manufacturer headquartered in Sunnyvale, California, specializes in advanced diagnostic...
- The Defense Department's Medical Supply Chain division awarded Cepheid Inc. a $17,952 firm fixed-price delivery order on August 4, 2025, for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The contract is set to be completed by August 18, 2025, with performance taking place at Cepheid's headquarters in Sunnyvale, California. This delivery order represents a continuation of the Defense Department's reliance on Cepheid's GeneXpert...
- The Defense Medical Supply Chain awarded a $4,080 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostic manufacturer headquartered in Sunnyvale, California, on July 21, 2025, with an ultimate completion date of July 28, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, carries no set-aside designation and pertains to COVID-19, influenza, and respiratory syncytial virus diagnostic solutions. The contract represents work performed under Cepheid's existing indefinite...
- The U.S. Defense Logistics Agency, through its Medical Supply Chain division, awarded a $20,400 firm fixed-price delivery order to Cepheid Inc. on August 20, 2025, with completion scheduled for August 27, 2025. This delivery order, designated 4569159076 XPCOV2/FLU/RSV-10, utilizes no set-aside designation and represents procurement of molecular diagnostic solutions from the Sunnyvale, California-based manufacturer. The award falls under Cepheid's larger Indefinite Delivery Vehicle...
- The U.S. Defense Department's Medical Supply Chain organization awarded a $2,024 firm fixed-price delivery order to Cepheid Inc. on August 7, 2025, with an ultimate completion date of August 14, 2025. The delivery order, designated XPRSTREPA-10, was issued without a set-aside designation to the Sunnyvale, California-based molecular diagnostics manufacturer. This delivery order represents a continuation of Cepheid's longstanding federal contract relationship, drawing from the company's existing...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F1PLVDelivery Order
The Defense Department's Medical Supply Chain division awarded a delivery order valued at $2,040 to Cepheid Inc. on August 21, 2025, with an ultimate completion date of August 28, 2025. This firm fixed-price delivery order, designated 4569178565 and titled "XPCOV2/FLU/RSV-10," requires no set-aside designation and represents a procurement of molecular diagnostic solutions for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). The work will be performed at Cepheid's headquarters in Sunnyvale, California. This delivery order is associated with one of Cepheid's two significant Indefinite Delivery Vehicles with the Department of Veterans Affairs, specifically the IDV with VA's Veterans Integrated Service Network 21, which is valued at $2.5 million and covers PCR testing for laboratory microbiology across multiple infectious disease categories through the established contract vehicle. Cepheid is a well-established manufacturer of molecular diagnostic systems and has maintained consistent federal contracting relationships across multiple agencies, including the VA, Indian Health Service, and Defense Logistics Agency. The company's expertise in providing GeneXpert diagnostic systems, reagents, test kits, and associated maintenance services positions it as a competitive vendor in the federal molecular diagnostics marketplace. This modest delivery order reflects routine procurement activity under an existing IDV agreement, enabling the Veterans Integrated Service Network to obtain critical diagnostic testing capabilities for infectious disease screening and laboratory microbiology applications.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 8/21/25 |